Russell Investments Group’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
126,158
+8,545
| +7% | +$80K | ﹤0.01% | 1981 |
|
|
2025
Q1 | $1.44M | Buy |
117,613
+88,591
| +305% | +$1.09M | ﹤0.01% | 1870 |
|
|
2024
Q4 | $384K | Buy |
29,022
+15,508
| +115% | +$205K | ﹤0.01% | 2367 |
|
|
2024
Q3 | $260K | Buy |
13,514
+231
| +2% | +$4.45K | ﹤0.01% | 2454 |
|
|
2024
Q2 | $273K | Buy |
13,283
+2,871
| +28% | +$58.9K | ﹤0.01% | 2393 |
|
|
2024
Q1 | $248K | Sell |
10,412
-6,674
| -39% | -$159K | ﹤0.01% | 2393 |
|
|
2023
Q4 | $369K | Sell |
17,086
-1,712
| -9% | -$37K | ﹤0.01% | 2307 |
|
|
2023
Q3 | $273K | Buy |
18,798
+10,298
| +121% | +$150K | ﹤0.01% | 2420 |
|
|
2023
Q2 | $178K | Buy |
+8,500
| New | +$178K | ﹤0.01% | 2491 |
|
|
2023
Q1 | – | Sell |
-39,595
| Closed | -$1.01M | – | 3378 |
|
|
2022
Q4 | $1.01M | Buy |
+39,595
| New | +$1.01M | ﹤0.01% | 1969 |
|
|
2021
Q3 | – | Sell |
-1,515
| Closed | -$26K | – | 3202 |
|
|
2021
Q2 | $26K | Sell |
1,515
-62,587
| -98% | -$1.07M | ﹤0.01% | 3170 |
|
|
2021
Q1 | $1.43M | Sell |
64,102
-42,687
| -40% | -$954K | ﹤0.01% | 2069 |
|
|
2020
Q4 | $2.38M | Sell |
106,789
-18,247
| -15% | -$406K | ﹤0.01% | 1663 |
|
|
2020
Q3 | $1.84M | Buy |
125,036
+20,914
| +20% | +$308K | ﹤0.01% | 1738 |
|
|
2020
Q2 | $1.54M | Sell |
104,122
-30,327
| -23% | -$449K | ﹤0.01% | 1794 |
|
|
2020
Q1 | $1.47M | Buy |
+134,449
| New | +$1.47M | ﹤0.01% | 1634 |
|
|
2019
Q1 | – | Sell |
-2,000
| Closed | -$9K | – | 3004 |
|
|
2018
Q4 | $9K | Sell |
2,000
-1,900
| -49% | -$8.55K | ﹤0.01% | 2893 |
|
|
2018
Q3 | $32K | Sell |
3,900
-100
| -3% | -$821 | ﹤0.01% | 2883 |
|
|
2018
Q2 | $28K | Buy |
+4,000
| New | +$28K | ﹤0.01% | 2863 |
|